Metraipolis › archive › dc_6e8f42e63afc

rs10010131A in WFS1 is Associated with Elevated Serum Urea in Type 2 Diabetes Patients Treated with SGLT2 Inhibitors — Europe PMC PMID:42078124

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42078124
DOI
10.2147/tcrm.s578286
License (as archived)
solo-consultazione
Archived
2026-11-03T04:07:57.533Z
SHA-256 of the archived text
9a43934619137771d181e2879c5b6a33f83541b4a7dabe1527e45bca469b42ad
Stable URL of this page
https://metraipolis.com/documento/dc_6e8f42e63afc

How to cite

rs10010131A in WFS1 is Associated with Elevated Serum Urea in Type 2 Diabetes Patients Treated with SGLT2 Inhibitors — Europe PMC PMID:42078124 — Europe PMC (en), https://europepmc.org/article/MED/42078124 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6e8f42e63afc (Metraipolis archive dc_6e8f42e63afc, sha256 9a43934619137771d181e2879c5b6a33f83541b4a7dabe1527e45bca469b42ad)
BibTeX
@misc{dc6e8f42e63afc,
  title = {rs10010131A in WFS1 is Associated with Elevated Serum Urea in Type 2 Diabetes Patients Treated with SGLT2 Inhibitors — Europe PMC PMID:42078124},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42078124},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6e8f42e63afc; sha256 9a43934619137771d181e2879c5b6a33f83541b4a7dabe1527e45bca469b42ad},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42078124. Agents can read the archived copy with the MCP tool read_document.